Filing Details

Accession Number:
0001209191-14-013255
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-21 18:39:17
Reporting Period:
2014-02-19
Filing Date:
2014-02-21
Accepted Time:
2014-02-21 18:39:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326104 Jeffrey David Medeiros 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Evp And Cto No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-19 1,042 $14.24 119,093 No 4 M Direct
Common Stock Acquisiton 2014-02-19 1,250 $35.78 120,343 No 4 M Direct
Common Stock Disposition 2014-02-19 2,292 $75.02 118,051 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-02-19 1,042 $0.00 1,042 $14.24
Common Stock Stock Option (right to buy) Disposition 2014-02-19 1,250 $0.00 1,250 $35.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,500 2021-02-15 No 4 M Direct
30,000 2022-02-14 No 4 M Direct
Footnotes
  1. Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
  2. The option was granted on 02/16/2011 for the right to buy 50,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
  3. The option was granted on 02/15/2012 for the right to buy 60,000 shares of common stock of the Issuer. Options vested monthly over 48 months from the date of grant. The options had a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01-$75.06. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.